<?xml version="1.0" encoding="UTF-8"?>
<p>Persons with OUD may face challenges obtaining medications for OUD or obtaining services from syringe services programs. Social distancing will increase the likelihood of opioid overdoses happening when there are no observers who can administer naloxone to reverse them and thus when they are more likely to result in fatalities. Emergency department physicians with increased caseloads may be less likely to initiate buprenorphine therapy for patients with OUD, which is an important component of mitigating the effects of the opioid crisis. In response to these challenges, the Substance Abuse and Mental Health Services Administration has advised opioid treatment programs to provide take-home medication more flexibly during the pandemic (
 <xref rid="r7-1212" ref-type="bibr">7</xref>) and the Drug Enforcement Administration has issued guidance to facilitate controlled substance prescribing (
 <xref rid="r8-1212" ref-type="bibr">8</xref>).
</p>
